SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-010605
Filing Date
2024-08-01
Accepted
2024-08-01 16:15:27
Documents
58
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nxtc-20240630x10q.htm   iXBRL 10-Q 1160356
2 EX-31.1 nxtc-20240630xex31d1.htm EX-31.1 12902
3 EX-31.2 nxtc-20240630xex31d2.htm EX-31.2 12683
4 EX-32.1 nxtc-20240630xex32d1.htm EX-32.1 12242
  Complete submission text file 0001558370-24-010605.txt   5178344

Data Files

Seq Description Document Type Size
5 EX-101.SCH nxtc-20240630.xsd EX-101.SCH 29607
6 EX-101.CAL nxtc-20240630_cal.xml EX-101.CAL 40187
7 EX-101.DEF nxtc-20240630_def.xml EX-101.DEF 109110
8 EX-101.LAB nxtc-20240630_lab.xml EX-101.LAB 324581
9 EX-101.PRE nxtc-20240630_pre.xml EX-101.PRE 217537
61 EXTRACTED XBRL INSTANCE DOCUMENT nxtc-20240630x10q_htm.xml XML 908214
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38905 | Film No.: 241166892
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)